Patent Assignment
Reel/Frame 038396/0850
Assignment of Assignor's Interest
Recorded: 2016-04-27
Pages: 7
Assignors
BAYEVER, ELIEL
Executed: 2016-04-12
DHINDSA, NAVREET
Executed: 2016-04-15
FITZGERALD, JONATHAN BASIL
Executed: 2016-04-14
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(5)
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/208,209 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/216,736 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/273,244 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/281,473 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/302,341 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Assignment of Assignor's Interest
Aug 29, 2016
From: BAYEVER, ELIEL; BLANCHETTE, SARAH F.; FITZGERALD, JONATHAN BASIL; GADDY, DANIEL F.
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 039566/0620 →
Release of Security Interest
Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →
Assignment of Assignor's Interest
May 1, 2017
From: MERRIMACK PHARMACEUTICALS, INC.
To: IPSEN BIOPHARM LTD.
Reel/Frame 042377/0696 →
Change of Address of Assignee
May 17, 2017
From: MERRIMACK PHARMACEUTICALS, INC.
To: IPSEN BIOPHARM LTD.
Reel/Frame 042522/0334 →